Seroepidemiology of toxoplasma gondii infection in tepehuanos in Durango, Mexico

Vector-Borne and Zoonotic Diseases

Volumn 12, Issue 2, 2012, Pages 138-142

  Alvarado Esquivel, Cosme ^a   Estrada Martínez, Sergio ^a   García López, Claudia Rosalba ^b   Rojas Rivera, Amparo ^b   Sifuentes Álvarez, Antonio ^a   Liesenfeld, Oliver ^c  

^a UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^b Independencia y Puebla ^*  (Mexico)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

cross sectional study; seroprevalence; Tepehuanos; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CAT; CONTROLLED STUDY; EATING HABIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEADACHE; HEARING IMPAIRMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; PRIORITY JOURNAL; RURAL POPULATION; SEROEPIDEMIOLOGY; SEROPREVALENCE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; COMORBIDITY; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOGISTIC MODELS; MALE; MEXICO; MIDDLE AGED; QUESTIONNAIRES; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

ANIMALIA; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 84856850855     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2011.0747     Document Type: Article

References (21)

1. Alvarado-Esquivel C, Cruz-Magallanes HM, Esquivel-Cruz R, et al. Seroepidemiology of Toxoplasma gondii infection in human adults from three rural communities in Durango State, Mexico. J Parasitol 2008; 94:811-816.
2. Alvarado-Esquivel C, Estrada-Mart́inez S, Pizarro-Villalobos H, et al. Seroepidemiology of Toxoplasma gondii infection in general population in a northern Mexican City. J Parasitol 2011; 97:40-43.
3. Alvarado-Esquivel C, Liesenfeld O, Torres-Castorena A, et al. Seroepidemiology of Toxoplasma gondii infection in patients with vision and hearing impairments, cancer, HIV, or undergoing hemodialysis in Durango, Mexico. J Parasitol 2010b; 96:505-508.
4. Alvarado-Esquivel C, Mercado-Suárez MF, Rodriguez-Briones A, et al. Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis 2007; 7:75.
5. Alvarado-Esquivel C, Rojas-Rivera A, Estrada-Mart́inez S, et al. Seroepidemiology of Toxoplasma gondii infection in a Menno-nite community in Durango State, Mexico. J Parasitol 2010a; 96:941-945.
6. Alvarado-Esquivel C, Sifuentes-Alvarez A, Narro-Duarte SG, et al. Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico. BMC Infect Dis 2006; 6:113.
7. Balasundaram MB, Andavar R, Palaniswamy M, et al. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol 2010; 128:28-32.
8. Chikweto A, Kumthekar S, Tiwari K, et al. Seroprevalence of Toxoplasma gondii in pigs, sheep, goats, and cattle from Grenada and Carriacou, West Indies. J Parasitol 2011 (in press).
9. Dubey JP. Toxoplasmosis of Animals and Humans, 2nd ed. Boca Raton, FL: CRC Press; 2010:1-199.
10. Hill D, Coss C, Dubey JP, et al. Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol 2011; 97:328-337.
11. Jones JL, Dargelas V, Roberts J, et al. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 2009; 49:878-884.
12. Jones JL, Kruszon-Moran D, Wilson M, et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001; 154:357-365. (Pubitemid 32756632)
13. Messier V, Lévesque B, Proulx JF, et al. Seroprevalence of Toxo-plasma gondii among Nunavik Inuit (Canada). Zoonoses Public Health 2009; 56:188-197.
14. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004; 363:1965-1976.
15. Noorbakhsh S, Memari F, Farhadi M, et al. Sensorineural hearing loss due to Toxoplasma gondii in children: a case-control study. Clin Otolaryngol 2008; 33:269-273. (Pubitemid 351799004)
16. Schlottmann A, Kleemann D, Kranz K, et al. Sudden deafness and increased toxoplasmosis IgM titer. Laryngorhinootologie 1996; 75:687-690.
17. Silva CS, Neves Ede S, Benchimol EI, et al. Postnatal acquired toxoplasmosis patients in an infectious diseases reference center. Braz J Infect Dis 2008; 12:438-441.
18. Sroka S, Bartelheimer N, Winter A, et al. Prevalence and risk factors of toxoplasmosis among pregnant women in Fortaleza, Northeastern Brazil. Am J Trop Med Hyg 2010; 83:528-533.
19. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30:1217-1258.
20. Uneke CJ, Duhlinska DD, Njoku MO, et al. Seroprevalence of acquired toxoplasmosis in HIV-infected and apparently healthy individuals in Jos, Nigeria. Parassitologia 2005; 47:233-236. (Pubitemid 43188248)
21. Walker M, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis 2005; 40:1005-1015. (Pubitemid 40418309)